Buck Bully
[The Motley Fool, Getty Images] Early-stage clinical trial results suggest adding mRNA-4157 to Keytruda can improve response rates. Moderna (NASDAQ:MRNA) announced encouraging results from a clinical trial with an experimental cancer vaccine. Treatment with the messenger RNA-based candidate, mRNA-4157, shrank tumors for five out of ten patients with head and neck squamous […]
[Business Insider, Reuters] Two drug companies at the forefront of the US race to develop a coronavirus vaccine, Moderna and Pfizer, are expected to join a pledge that promises to put safety before speed. In an early draft obtained by the Wall Street Journal, the companies promise to only seek emergency FDA […]
[CNN] While anti-vaxxers flood social media with lies about the upcoming coronavirus vaccine — that it contains monkey brains, that it’s a CIA plot to take over the world — the government’s multi-billion-dollar vaccine effort has yet to come up with a public education campaign to counteract that propaganda. “We […]
[Business Insider] Goldman Sachs lifted its price target for Moderna stock to $105 from $63 on Monday after first trials for its coronavirus drug showed “encouraging” results. Moderna announced Monday that all 45 volunteers in the trial produced antibodies to protect against COVID-19 infection. Shares jumped as much as 39% on the news. The new […]
[WebMD, Stanford School of Medicine] If testing could show who’s had COVID-19, even if they didn’t have symptoms, we might not have to worry so much about getting it. Companies could bring back recovered workers, and many health care workers could breathe a sigh of relief. Such a test would […]